VasThera to Attend Bio Japan 2023

VasThera Co., Ltd. (VasThera) participated in the Bio Japan 2023 conference in Yokohama, Japan in October.

Held for three days from October 11th, Bio Japan is the Asia's largest partnering conference for the pharmaceutical and biotechnology sectors, which began in 1986 and 

attracted more than 1500 global biotech companies this year. 

Dr. Sang Won Kang, CEO of VasThera, participated in partnering meetings to promote VasThera's pipeline of innovative new drugs to pharmaceutical companies from 

Japan and other countries, as well as business collaborations. VasThera strengthened collaborative relationships with companies with whom already have established 

existing networks and held active business discussions with new companies.

VasThera will continue to focus on R&D for innovative drug development and build strategic partnerships with global pharmaceutical and biotech companies.